Papers
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7076.253 (Published 25 January 1997) Cite this as: BMJ 1997;314:253
Related articles
- This Week In The BMJ Published: 25 January 1997; BMJ 314 doi:10.1136/bmj.314.7076.0a
- Editorial Published: 14 July 2005; BMJ 331 doi:10.1136/bmj.331.7509.121
See more
- Toxicologists investigate cases of hand deformities in German babiesBMJ September 17, 2019, 366 l5607; DOI: https://doi.org/10.1136/bmj.l5607
- Dutch physician sues FDA for blocking her abortion services in United StatesBMJ September 11, 2019, 366 l5511; DOI: https://doi.org/10.1136/bmj.l5511
- “Some exercise is good, more is better,” say medical chiefs in new guidanceBMJ September 07, 2019, 366 l5470; DOI: https://doi.org/10.1136/bmj.l5470
- Planned Parenthood rejects restrictive US government funding and “gag rule”BMJ August 20, 2019, 366 l5227; DOI: https://doi.org/10.1136/bmj.l5227
- Scotland’s breast screening review does not tackle benefit-risk issueBMJ July 31, 2019, 366 l4954; DOI: https://doi.org/10.1136/bmj.l4954
Cited by...
- EULAR recommendations for the management of antiphospholipid syndrome in adults
- Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
- High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant
- Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins
- Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics
- The antiphospholipid syndrome: still an enigma
- Anticoagulation in pregnancy complications
- Preventing pregnancy loss
- Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study
- Is heparin a placental anticoagulant in high-risk pregnancies?
- Consultative Hematology: The Pregnant Patient Pregnancy Loss
- SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage
- Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the HepASA Trial
- Clark, et al, reply
- How I treat the antiphospholipid syndrome
- Anticoagulants and pregnancy: When are they safe?
- Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial
- How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review
- Management of Hereditary Hypercoagulable Disorders
- Investigation of recurrent miscarriages
- Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
- Clinical management of thrombophilia-related placental vascular complications
- Antiphospholipid syndrome: an overview
- Pregnancy in systemic lupus erythematosus
- How to treat women with antiphospholipid antibodies in pregnancy?
- Thrombophilia in pregnancy
- Thrombophilia testing: what do we think the tests mean and what should we do with the results?
- Testing for and Clinical Significance of Anticardiolipin Antibodies
- Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies
- Low-dose aspirin plus heparin led to a higher rate of live births in women with recurrent miscarriages and phospholipid antibodies
- Systemic lupus erythematosus complicated by antiphospholipid antibody syndrome
- ASPIRIN PLUS HEPARIN FOR MISCARRIAGE DUE TO PHOSPHOLIPID ANTIBODIES
- Aspirin Plus Heparin for Miscarriage Due to Phospholipid Antibodies
- Antiphospholipid (Hughes') syndrome